Quantitative ultrasound radiomics guided adaptive neoadjuvant chemotherapy in breast cancer: early results from a randomized feasibility study

Quantitative ultrasound radiomics guided adaptive neoadjuvant chemotherapy in breast cancer: early results from a randomized feasibility study

BackgroundIn patients with locally advanced breast cancer (LABC) receiving neoadjuvant chemotherapy (NAC), quantitative ultrasound (QUS) radiomics can predict final responses early within 4 of 16-18 weeks of treatment. The current study was planned to study the feasibility of a QUS-radiomics model-g...

Full description

Bibliographic Details
Main Authors: Archya Dasgupta, Daniel DiCenzo, Lakshmanan Sannachi, Sonal Gandhi, Rossana C. Pezo, Andrea Eisen, Ellen Warner, Frances C. Wright, Nicole Look-Hong, Ali Sadeghi-Naini, Belinda Curpen, Michael C. Kolios, Maureen Trudeau, Gregory J. Czarnota
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
breast cancer
radiomics
quantitative ultrasound (QUS)
neoadjuvant chemotherapy
adaptive chemotherapy
artificial intelligence
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1273437/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1273437/full

Similar Items